SCHEMBL7154076

SCHEMBL7154076

COc1ccc(Nc2c3ncnc-3nc(N)n2C2CCC(N)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK9 P45984 6/20 0.44
▸ MAPK8 P45983 5/20 0.44
▸ MAPK10 P53779 5/20 0.44
▸ MAPK14 Q16539 4/20 0.44
▸ RIPK2 O43353 1/20 0.41
▸ PRKDC P78527 3/20 0.38
▸ MEN1 O00255 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ PIK3CA P42336 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ CHKA P35790 1/20 0.36
▸ USP2 O75604 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MAPKAPK2 P49137 2/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7154804 0.73 RIPK2 (0.33) RIPK2
Hydrochloric Acid SCHEMBL4898580 0.72 RIPK2 (0.32) RIPK2
SCHEMBL7157428 0.70 MAPK6 (0.39) MEN1KMT2AMAPKAPK2
SCHEMBL7157418 0.70 MAPK6 (0.39) MEN1KMT2AMAPKAPK2
Hydrochloric Acid SCHEMBL4897810 0.69 MAPK6 (0.38) MEN1KMT2AMAPKAPK2
SCHEMBL7154081 0.61 NR4A1 (0.35) MAPK9MAPK8MAPK10MAPK14MEN1
SCHEMBL4902038 0.61 MEN1 (0.46) MEN1KMT2APIK3CAGAAL3MBTL1
SCHEMBL29130622 0.60 MAPT (0.73) MEN1KMT2AGAAL3MBTL1NPC1
SCHEMBL5390852 0.58 MEN1 (0.61) MEN1KMT2AGAAL3MBTL1CYP1A2
SCHEMBL11812041 0.58 MAPT (0.81) MEN1KMT2AGAAL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 — — EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 — — WO disclosed
Send feedback